Gene · 2073
Papers2,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BRCA Mutations-The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers. | Int J Mol Sci | 2023 | 36902416 | PubTator, text mining | PubMed |
| DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining Immunotherapy. | Cancers (Basel) | 2023 | 36900418 | PubTator, text mining | PubMed |
| Identifying polymorphic cis-regulatory variants as risk markers for lung carcinogenesis and chemotherapy responses in tobacco smokers from eastern India. | Sci Rep | 2023 | 36899086 | PubTator, text mining | PubMed |
| A disease-associated XPA allele interferes with TFIIH binding and primarily affects transcription-coupled nucleotide excision repair. | Proc Natl Acad Sci U S A | 2023 | 36893274 | PubTator, text mining | PubMed |
| Structural modeling and analyses of genetic variations in the human XPC nucleotide excision repair protein. | J Biomol Struct Dyn | 2023 | 36890638 | PubTator, text mining | PubMed |
| TP73-AS1 rs3737589 Polymorphism is Associated With the Clinical Stage of Colorectal Cancer. | Evid Based Complement Alternat Med | 2023 | 36874617 | PubTator, text mining | PubMed |
| Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study. | PLoS One | 2023 | 36857355 | PubTator, text mining | PubMed |
| Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. | Signal Transduct Target Ther | 2023 | 36843114 | PubTator, text mining | PubMed |
| Orthologs of Human-Disease-Associated Genes in Plants Are Involved in Regulating Leaf Senescence. | Life (Basel) | 2023 | 36836919 | PubTator, text mining | PubMed |
| DNA Damage and Repair in Eye Diseases. | Int J Mol Sci | 2023 | 36835325 | PubTator, text mining | PubMed |
| Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations. | Cancers (Basel) | 2023 | 36831665 | PubTator, text mining | PubMed |
| Aging, Physical Exercise, Telomeres, and Sarcopenia: A Narrative Review. | Biomedicines | 2023 | 36831134 | PubTator, text mining | PubMed |
| Network and pathway-based analysis of genes associated with esophageal squamous cell carcinoma. | Ann Transl Med | 2023 | 36819552 | PubTator, text mining | PubMed |
| Cell migration is impaired in XPA-deficient cells. | FASEB Bioadv | 2023 | 36816512 | PubTator, text mining | PubMed |
| Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort. | BJUI Compass | 2023 | 36816149 | PubTator, text mining | PubMed |
| First genetic characterization of Xeroderma pigmentosum in Libya: High frequency of XP-C founder mutation. | Mol Genet Genomic Med | 2023 | 36812379 | PubTator, text mining | PubMed |
| Biochemical characterization of the RNA-binding and RNA-DNA strand exchange activities of the human RAD52 protein. | J Biochem | 2023 | 36811351 | PubTator, text mining | PubMed |
| A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma. | BMC Med Genomics | 2023 | 36803971 | PubTator, text mining | PubMed |
| PARP1 associates with R-loops to promote their resolution and genome stability. | Nucleic Acids Res | 2023 | 36794853 | PubTator, text mining | PubMed |
| The Spectrum of MORC2-Related Disorders: A Potential Link to Cockayne Syndrome. | Pediatr Neurol | 2023 | 36791574 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2073/papers?page=12